Westmead Dermatology
Striving towards disease-free skin
On the 2nd of December, we have successfully held our first “Skin effects of systemic anti-cancer therapies” education day at Westmead Hospital. Education is one of the missions of the CTSR (Centre for Translational Skin Research), and were sharing our knowledge regarding the diagnosis and management of skin effects of systemic oncology medications with dermatologists, …
Shelley Hwang has just received a copy of the book Adverse Reactions to Biologics that includes her chapter on the monoclonal antibodies used in Melanoma patients: ipilimumab, nivolumab and pembrolizumab. Shelley is one of the CTSR experts in the cutaneous effects of checkpoint inhibitors used in patients with cancers. Last Updated on 6 December 2017 …
Naevus lightening is a fascinating phenomenon found in patients on BRAF inhibitors and MEK inhibitors combination therapy (BiMiC) and checkpoint immunotherapy. We have recently published a study unravelling the mystery underlining this phenomenon. We biopsied 7 lightened naevi from metastatic melanoma patients on either BiMiC or checkpoint immunotherapy such as pembrolizumab. Under the microscope, we …
The Department of Dermatology at Westmead Hospital hit the headlines in Western Sydney Local Health District. Dr Bruno Blaya Alvarez has been presented with the 2017 “Registrar of the Year” award. Bruno arrived from Spain in March this year, and he’s completing a 2-year up-skill program in our Unit. It is amazing how well Bruno …
